The efficacy analysis of immunotherapy rechallenge after progression from first-line chemo-immunotherapy in advanced non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Shi W 

PROVIDER: S-EPMC12918556 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature